James Lindsay is the Professor of Inflammatory Bowel Disease and a Consultant Gastroenterologist. He studied medicine at the Universities of Cambridge and Oxford and qualified in 1993. He completed his PhD in mucosal immunology at Imperial College London. His NHS base is Barts Health NHS Trust and he also holds an academic position at Barts and the London School of Medicine and Dentistry, Queen Mary University of London. Along with a full multidisciplinary team he runs the adolescent and adult IBD service at The Royal London Hospital as well as a private clinic at the London Digestive Centre. He performs endoscopy and colonoscopy at the Princess Grace Hospital and is an accredited bowel cancer screening colonoscopist.
He is a past Education Officer and Governing Board Member of the European Crohn’s and Colitis Organisation (ECCO). He has chaired working groups for the ECCO consensus on the management of Crohn’s disease and ulcerative colitis. He is the British Society of Gastroenterology (BSG) national societies representative to United European Gastroenterology and is a member of the International Organisation of IBD (IOIBD).
Professor Lindsay serves on the BSG IBD Clinical Trials Steering Group and is Chief Investigator for a series of investigator-led and commercial clinical trials in IBD. In addition, he leads a program of translational science research.